Treace Medical Concepts Inc (TMCI)
4.985
-0.64
(-11.46%)
USD |
NASDAQ |
May 17, 16:00
4.985
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Debt to Equity Ratio: 0.42 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.42 |
| December 31, 2023 | 0.3843 |
| September 30, 2023 | 0.384 |
| June 30, 2023 | 0.3525 |
| March 31, 2023 | 0.3349 |
| December 31, 2022 | 0.8708 |
| September 30, 2022 | 0.8462 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.733 |
| March 31, 2022 | 0.3388 |
| December 31, 2021 | 0.3155 |
| September 30, 2021 | 0.3011 |
| June 30, 2021 | 0.2845 |
| March 31, 2021 | -42.74 |
| December 31, 2020 | 39.92 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-42.74
Minimum
Mar 2021
39.92
Maximum
Dec 2020
0.1961
Average
0.3682
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 0.0155 |
| Xtant Medical Holdings Inc | 0.5683 |
| Asensus Surgical Inc | 0.00 |
| Catheter Precision Inc | 0.004 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 242.73M |
| Total Liabilities (Quarterly) | 116.34M |
| Shareholders Equity (Quarterly) | 126.39M |
| Current Ratio | 3.983 |
| Net Debt Paydown Yield | -0.01% |